We are pleased to announce the first release of new exams for the 2010 calendar year! Please use this information to assist with using these exams during your screening process.
2010 Trauma ICU
The 2010 Trauma ICU Exam is a new exam that determines clinician competency based on a critical patient population inclusive of all pathologies familiar to the Trauma ICU setting. The Pharmacology component has been integrated into this exam; therefore you will not need to administer a separate Pharmacology Exam.
However, you will need to administer the Dysrhythmia Version 2.0 Exam to determine competency for rhythm recognition, as the new Critical Care exams do not contain rhythm strips. Attempting to include the Dysrhythmia strips in the newer exams would have created a very lengthy exam for the applicant.
This exam has a corresponding 2010 Trauma ICU Skills Checklist.
2010 Surgical ICU
The 2010 Surgical Intensive Care Unit (SICU) Exam determines clinician competency based on the patient population inclusive of the critical post-operative phase. The Pharmacology component has been integrated into this exam; therefore you will not need to administer a separate Pharmacology Exam.
However, you will need to administer the Dysrhythmia Version 2.0 Exam to determine competency for rhythm recognition, as the new Critical Care exams do not contain rhythm strips. Attempting to include the Dysrhythmia strips in the newer exams would have created a very lengthy exam for the applicant.
***If you want the newly validated exams included in your profiles, you must change your profiles to reflect this. ***
Your profiles can be modified by following a few simple steps. For step-by-step assistance, check out the training video – “Creating Profiles”.
For your convenience, the “Creating Profiles” training video can also be found in your NurseTesting account under the Help tab! Remember that for the protection of your account; only Admins have access to modifying profiles!
We hope this will assist you in the implementation of these new exams!
Facebook Comments:
